Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.34 |
| ▸ | KDM2B | Q8NHM5 | 7/20 | 0.33 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5108503 | 0.78 | ALOX5 (0.40) | HRH3ALOX5CHRM4 | |
| SCHEMBL5107827 | 0.77 | ALOX5 (0.42) | HRH3ALOX5ACACBC5AR1CCNA2 | |
| SCHEMBL5115597 | 0.75 | ALOX5 (0.41) | HRH3ALOX5ACACBC5AR1CCNA2 | |
| SCHEMBL5107733 | 0.72 | ALOX5 (0.43) | HRH3ALOX5ACACBC5AR1CCNA2 | |
| Hydrochloric Acid SCHEMBL5116833 | 0.71 | ALOX5 (0.42) | HRH3ALOX5ACACBC5AR1CCNA2 | |
| SCHEMBL5116039 | 0.70 | ALOX5 (0.46) | HRH3ALOX5ACACBC5AR1CCNA2 | |
| SCHEMBL6254453 | 0.69 | CHRNA7 (0.50) | — | |
| SCHEMBL6253234 | 0.68 | CHRM4 (0.39) | HRH3KDM2BCHRM4 | |
| SCHEMBL26251506 | 0.67 | HRH3 (0.41) | HRH3ALOX5ACACBCCNA2CDK2 | |
| SCHEMBL29904626 | 0.66 | HRH3 (0.48) | HRH3C5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1551843-A1 | DIAZABICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CNS AND OTHER DISORDERS | Pfizer Products Inc. (US) | 2005-07-13 | — | — | EP | claimed |
| WO-2004024729-A1 | DIAZABICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CNS AND OTHER DISORDERS | PFIZER PRODUCTS INC. (US) | 2004-03-25 | — | — | WO | claimed |